Pacer Advisors Inc. Raises Holdings in USANA Health Sciences, Inc. (NYSE:USNA)

Pacer Advisors Inc. grew its holdings in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 14.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 467,352 shares of the company's stock after acquiring an additional 58,597 shares during the period. Pacer Advisors Inc. owned about 2.45% of USANA Health Sciences worth $21,143,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. Quest Partners LLC purchased a new stake in USANA Health Sciences in the fourth quarter valued at $66,000. CWM LLC lifted its position in USANA Health Sciences by 21.8% in the first quarter. CWM LLC now owns 1,543 shares of the company's stock valued at $75,000 after acquiring an additional 276 shares during the last quarter. BOKF NA lifted its position in USANA Health Sciences by 274.5% in the first quarter. BOKF NA now owns 2,771 shares of the company's stock valued at $133,000 after acquiring an additional 2,031 shares during the last quarter. Trexquant Investment LP purchased a new stake in USANA Health Sciences in the fourth quarter valued at $266,000. Finally, Price T Rowe Associates Inc. MD lifted its position in USANA Health Sciences by 9.2% in the first quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company's stock valued at $284,000 after acquiring an additional 494 shares during the last quarter. Institutional investors and hedge funds own 54.25% of the company's stock.

USANA Health Sciences Price Performance

Shares of NYSE:USNA traded down $0.52 on Monday, reaching $38.08. The company's stock had a trading volume of 111,561 shares, compared to its average volume of 79,758. USANA Health Sciences, Inc. has a 52-week low of $36.05 and a 52-week high of $60.03. The stock's 50-day moving average is $40.90 and its two-hundred day moving average is $44.41. The stock has a market capitalization of $725.46 million, a P/E ratio of 12.05, a PEG ratio of 1.28 and a beta of 0.90.

USANA Health Sciences (NYSE:USNA - Get Free Report) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $0.54 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.65 by ($0.11). USANA Health Sciences had a return on equity of 11.13% and a net margin of 6.29%. The firm had revenue of $212.87 million for the quarter, compared to analyst estimates of $218.64 million. During the same quarter last year, the firm earned $0.89 earnings per share. Equities analysts forecast that USANA Health Sciences, Inc. will post 2.5 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other USANA Health Sciences news, insider Paul A. Jones sold 6,266 shares of the company's stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total transaction of $240,489.08. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, Director Gilbert A. Fuller sold 674 shares of the firm's stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $39.69, for a total transaction of $26,751.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Paul A. Jones sold 6,266 shares of the firm's stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $38.38, for a total transaction of $240,489.08. The disclosure for this sale can be found here. Over the last three months, insiders have sold 7,940 shares of company stock worth $311,670. 0.33% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of brokerages recently weighed in on USNA. DA Davidson reduced their price target on shares of USANA Health Sciences from $46.00 to $38.00 and set a "neutral" rating for the company in a research report on Thursday, July 25th. StockNews.com cut shares of USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a report on Wednesday, July 24th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.